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Congenital heart disease (CHD) is the most common 
congenital malformation [1] in fetuses. It affects eight per 
1,000 live births and is more common antenatally [2-5]. In 
beginning, cardiac evaluation was confined to pregnancies at 
increased risk of CHD, such as those with a family history of 
CHD or where extracardiac malformations had been detected. 
However, up to 86% of CHD occurs in pregnancies where 
there are no known high risk features [6], emphasizing the 
need for an effective fetal cardiac screening program for all 
pregnancies [7,8]. For this reason, in the mid 80’s started 
the idea of teaching the obstetrician to assess the heart in a 
simplified form during routine obstetric scanning [9,10].
Four chamber view scanning became an integral part of 
the fetal anatomical survey in many countries by the end 
of the 1980s [9,10]. However, prenatal screening based on 
visualization of the four-chamber view has much lower 
sensitivity [6,11]. This is partly because the four-chamber 
view may appear normal in cases of many anomalies, such as 
transposition of the great vessels, tetralogy of Fallot, double 
outlet right ventricle, truncus arteriosus, pulmonary or aortic 
stenosis/atresia and coarctation of the aorta. Anomalies of the 
great vessels are associated with an abnormal four-chamber 
view in 30% of cases [12].
When four-chamber and great vessels view are examined, 
the sensitivity of ultrasound screening for congenital heart 
defects increases from approximately 30% to 69–83% 
[6,11,13]. Therefore, we support the idea of evaluation both 
the four-chamber view and the outflow tracts (Figure 1). Then, 
we could improve the rate of prenatal detection of congenital 
heart disease. 
In 2006, the International Society of Ultrasound in 
Obstetrics and Gynecology (ISUOG) published a guideline 
in which they described the “basic” and “extended basic” 
cardiac ultrasound examinations [14]. The intention was to 
standardize the assessment and to maximize the detection 
of heart anomalies during the second-trimester scan 
(Figure 1). However, we agree that a comprehensive fetal 
echocardiography should be performed when heart anomalies 
are suspected. One of the problems to follow this guideline is 
the difficulty of obtaining images of the outflow tracts.
This happens because unlike the four-chamber view, the 
aorta and pulmonary artery do not lie in a single axis. In 
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Fig. 1 - Images for evaluating the fetal cardiac screening by two-
dimensional ultrasound. A: four-chamber view of the fetal heart. B: 
left ventricular outflow tract (LVOT). C: right ventricular outflow 
tract (RVOT). D: three-vessel view of the fetal heart. LV: left ventricle. 
RV: right ventricle. LA: left atrium. RA: right atrium. P: pulmonary 
artery. Ao: aorta. SVC: superior vena cava
Rastreamento das doenças cardíacas congênitas fetais: o desafio continua
VI
Rev Bras Cir Cardiovasc | Braz J Cardiovasc Surg
compliance to DeVore study [15], we state that it is necessary 
experienced hands to view the outflow tract. Accordingly, it 
is important additional training.
The development of new technologies is gaining strength 
as they; theoretically, facilitate the evaluation of the fetal 
heart exam including the outflow tracts. Four-dimensional 
ultrasonography (4DUS) with spatio-temporal image 
correlation (STIC) technology allows the acquisition of a 
volume dataset from the fetal heart, and displays a cineloop 
of a complete single cardiac cycle in motion. Moreover, STIC 
offers the advantage of offline assessment of cardiac structures, 
connections, and functions [16-18] (Figure 2).
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Fig. 2 - Images for evaluating the fetal cardiac screening by four-
dimensional ultrasonography with spatiotemporal image correlation 
(STIC) by multiplanar mode. A: four-chamber view of the fetal heart. 
B: three-vessel view of the fetal heart. C: left ventricular outflow tract 
(LVOT) and right ventricular outflow tract (RVOT)
The STIC technology has several tools to analyze all 
cardiac structures: dynamic multiplanar mode, render mode, 
omni view, M mode, volume analysis, tomographic ultrasound 
imaging (TUI). These are new technologies that are still in 
development and in study.
Despite the great efforts made so far, the STIC is still 
considered an additional method in echocardiography and, 
rarely, they are available in daily practice. There are many 
inherent difficulties in obtaining adequate cardiac images in a 
STIC [16], for example: the fetal position may vary during the 
exam; fetal movement during the acquisition of the volume; 
higher maternal body mass indices or oligohydramnios may 
make images more difficult and acquiring the images of the 
heart can be time consuming.
However, we believe that the new methods will be 
very useful for tracking in the future. Technology tends to 
advance and sensitivity of this new method will continue 
improving. Thereby, the 3D/4D technology allows for a more 
comprehensive and practical assessment of CHD in the fetus.
Antenatal screening can offer a number of benefits. The 
identification of CHD can facilitate early therapy and to 
prevent a cardiac decompensation. Other benefits include 
opportunities to counsel parents, to screen for co-existing 
abnormalities, to plan peripartum management and intrauterine 
intervention in some cases. In severe cases, some patients 
choose for termination of pregnancy. Ultimately, the increased 
detection rates of congenital heart disease reduce perinatal 
morbidity and mortality. We believe that adequate training 
associated with a proper use of new technologies may improve 
the rate of diagnose CHD.
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